John Sweetenham, MD, PhD

Editorials by John Sweetenham, MD

Editorial

Oncology Care Model: Progress along the learning curve

HemOnc Today, November 10, 2019
John Sweetenham, MD
Recognizing the importance of addressing value in cancer care, I have been an interested observer, until recently, of the progress of CMS’s…
Editorial

Access to cancer clinical trials may not entirely level the playing field

HemOnc Today, October 10, 2019
John Sweetenham, MD
There is compelling evidence that reducing variability in cancer care can improve patient outcomes and limit costs. Current alternative payment…
Editorial

The unspoken truth about financial toxicity

HemOnc Today, September 10, 2019
John Sweetenham, MD
As time goes by, I realize my clinical comfort zone is shrinking. This phenomenon is probably more characteristic of those of us in academic centers…
Editorial

Patient access to new cancer treatments — an uncertain and fragile process

HemOnc Today, August 10, 2019
John Sweetenham, MD
As Tom Brokaw eloquently stated, uncertainty is at the heart of the cancer experience for our patients. It impacts many aspects of their lives, from…
Editorial

Potholes on the road to improved cancer outcomes

HemOnc Today, July 10, 2019
John Sweetenham, MD
“Continuous improvement is better than delayed perfection.” – Mark Twain During my high school years, late June and early July…
Editorial

Timing matters — so do breaks

HemOnc Today, June 10, 2019
John Sweetenham, MD
As oncologists, making our services as convenient and accessible as possible for our patients is a major goal and an ongoing challenge. Providing…
Editorial

Difficult decisions: Slow changes for overuse of therapy at end of life

HemOnc Today, May 10, 2019
John Sweetenham, MD
For the past few years, one component of my role as a member of the physician leadership team for oncology has been to authorize some types of…
Editorial

The potential benefits (and pitfalls) of real-world evidence in oncology

HemOnc Today, April 10, 2019
John Sweetenham, MD
Years ago, on a visit to Cambridge in the U.K., I walked across one of the many parks in that beautiful city. The park separated a middle-class…
Editorial

Saying goodbye

HemOnc Today, March 10, 2019
John Sweetenham, MD
I will shortly be leaving Utah to take up a new position at Harold C. Simmons Comprehensive Cancer Center at UT Southwestern in Dallas. Anyone who…
Editorial

Second opinions in oncology: Reducing frustration

HemOnc Today, February 10, 2019
John Sweetenham, MD
At a regular cancer service-line meeting last week, we reviewed our experience with pathology over-reads. Like many other centers, we at Huntsman…